Moreover, Rycal drugs were established in several studies as potent stabilizers of dysfunctional RyR1 channels linked to congenital myopathies with symptoms similar to SAMS (17, 19, 42). This evidence concerns the gene RYR1 and short stature-auditory canal atresia-mandibular hypoplasia-skeletal anomalies syndrome.